Filing Flows › Cerenome (CNSY) › Q2 2026
Cerenome (CNSY) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
Cerenome (CNSY) reported revenue of $411K for the second quarter 2026 (Q2 2026), -70% from a year earlier and -60% from the quarter before.
Cerenome, Q2 2026: revenue $411K (-70% year over year), net loss $9.0M, operating cash flow −$7.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $411K | -60% | -70% |
| Operating profit | −$9.1M | — | — |
| Net earnings | −$9.0M | — | -275% |
| Operating cash flow | −$7.1M | — | — |
What changed
Revenue was $411K in Q2 2026, down 70% year over year and down 60% from the previous quarter.
Operating costs exceeded revenue by $9.1M, an operating margin of -2203.6%. Total costs grew 223% against a revenue fall of 70%. The fastest-growing cost line was Research & development (+242%). The quarter ended with a net loss of $9.0M, wider than the previous quarter's $6.9M loss.
Operating cash flow was −$7.1M. Non-cash charges added back $137K of depreciation and amortization and $830K of share-based compensation. Working capital and other items added $907K. Capital expenditures of $499K exceeded it, leaving free cash flow of −$7.6M.
Questions
What was Cerenome's revenue in the second quarter 2026?
Cerenome (CNSY) reported revenue of $411K for the second quarter 2026 (Q2 2026), -70% from a year earlier and -60% from the quarter before.
Source: Cerenome 10-Q on SEC EDGAR.